Summary: Autologous bone-patellar tendon-bone autograft is a common choice for anterior cruciate ligament reconstruction and from both biologic and biomechanical perspectives is well-suited for this purpose. A centrally harvested, 10 mm wide patellar tendon graft has an estimated initial load-to-failure of 2977 N, and interference screw fixation of associated bone blocks provides initial pull-out strength as high as 640 N. After reconstruction, both intraarticular and extraarticular portions of the graft experience significant changes. The intraarticular portion of the graft undergoes a prolonged histologic, morphologic, and structural evolution known as ligamentization. The extraarticular portion of the graft becomes rapidly incorporated into surrounding bone tunnels over the weeks after implantation. The use of biologics to accelerate this process holds promise. This review summarizes relevant data regarding the anatomy, biology, and biomechanics of the anterior cruciate ligament, patellar tendon, and anterior cruciate ligament reconstruction with autogenous bone-patellar tendon-bone graft.
The anatomy and biomechanics of the anterior cruciate ligament are complex, and regardless of technique or graft selection, the clinical ability to recapitulate normal anterior cruciate biomechanics has not yet been demonstrated in the literature. Nevertheless, among the multiplicity of graft selections available, the bone-patellar tendon-bone (BPTB) graft possesses several properties that make a favorable choice for anterior cruciate ligament reconstruction.
ANATOMY AND BIOMECHANICS OF THE NATIVE ANTERIOR CRUCIATE LIGAMENT

Anatomy
The anterior cruciate ligament (ACL) is an intraarticular, intrasynovial structure that comprises 2 bundles named for the location of their respective tibial attachment sites: anteromedial and posterolateral. 4, 30 Collectively, the 2 bundles attach proximally along the posteromedial aspect of the lateral femoral condyle in a circular area measuring approximately 113 mm 2 The tibial attachment site is elliptical in shape with an average area of 136 mm 2 and is situated a mean of 15 mm posterior to the anterior border of the tibial articular surface, posterior to the attachment of the anterior horn of the medial meniscus and medial to the attachment of the anterior horn of the lateral meniscus (Fig. 1) . 30, 34 Both the proximal and distal attachment sites of the ligament are considerably broader than its midsubstance, the crosssectional area of which averages 40 mm 2 . 34 The anteromedial and posterolateral bundles are not arranged in a simple linear fashion, but rotate externally around each other as they extend from the proximal femoral to the distal tibial attachment. 71 Cadaveric sectioning studies with isolated preservation of the ACL demonstrate slight internal rotation of the tibia on the femur. 71 The primary blood supply to the cruciate ligaments arises from the middle geniculate artery, which branches directly off of the popliteal artery and pierces the posterior capsule to form a periligamentous plexus (Figs. 2 and 3). 4 Disruption of this periligamentous plexus gives rise to the hemarthrosis often present after acute injury to the ACL.
The posterior articular nerve, a branch of the posterior tibial nerve, provides innervation to the ACL. 46 In a manner analogous to the middle geniculate artery, the posterior articular nerve pierces the posterior capsule to form a periligamentous plexus. Furthermore, mechanoreceptors are found on the surface of the ligament, arranged parallel to the course of the collagen fascicles, and clustered near the femoral attachment site. 74 These mechanoreceptors serve a presumptive proprioceptive role for the knee joint, facilitating muscular adaptation to movement and theoretically enhancing dynamic joint stability. 74 On a microstructural level, the ACL consists primarily of type I collagen in longitudinally arranged fibrils that increase in size from proximal to distal and range from 20 m to 270 m in diameter (Fig. 4) . 7 Small amounts of type III and type VI collagen are also present, particularly near the proximal and distal attachment sites. Both the proximal and distal attachment sites exhibit the four zones characteristic of "direct" ligament insertion: ligament, unmineralized fibrocartilage, mineralized fibrocartilage, and subchondral bone. 39 This transitional region between ligament and bone comprises a gradual change in stiffness that is thought to permit a more advantageous distribution of stress at the attachment sites than would an "indirect" type of insertion that consists simply of direct soft-tissue attachment to bone (ie, Sharpey fibers).
The capacity of the anterior cruciate ligament to heal spontaneously is an area of increasing interest. 58 Despite the fact that the injured ACL exhibits a histologic healing response similar to that observed for other ligaments (eg, medial collateral ligament), consisting of inflammation, epiligamentous regeneration, proliferation, and remodeling, spontaneous healing of the ligament has rarely been observed experimentally or reported clinically (Fig.  5) . 49, 58 Unlike other segments of dense connective tissue, a synovial cell layer with abundant ␣-smooth muscle actin-containing cells forms over the stump of the injured ACL, which may present a physical barrier to ligament healing. 58 An additional impediment to spontaneous healing is the fact that a fibrin scaffold, or post-traumatic clot, is not observed to form between torn ends of the ligament, perhaps because of the presence of fibrinolytic enzymes in synovial fluid. 2, 35 
Biomechanics
The ACL functions primarily to limit anterior translation of the tibia in relation to the femur, and secondarily to limit varus and valgus stress, and internal rotatory subluxation. 53 With respect to its role as a secondary restraint, sectioning studies with the knee in 5 degrees of flexion have shown the contribution of the ACL to be as high as 12% of the total restraining moment to valgus stress, its role diminishing with increasing flexion angles, and as high as 19.7% of the total restraining moment to varus stress, again its role decreasing with increasing flexion angles. 32 Fibers from the posterolateral and anteromedial bundles are thought to be recruited differentially as the knee moves through a full range of motion. 29 The posterolateral bundle of the ACL is thought to function as the principle restraint to anterior translation from 0 degrees to approximately 45 degrees of flexion, while the anteromedial bundle is thought to function as the principle restraint at higher flexion angles. 29 Based on in vitro studies, the anteromedial bundle has been observed to shorten from 0 degrees to 30 degrees of flexion, return to its baseline length from 30 degrees to 70 degrees of flexion, and lengthen from 70 degrees to 120 degrees of flexion. 21 Conversely, the posterolateral bundle has been observed to reach maximum length with the knee in full extension and experience progressive shortening as the knee flexes, which together with the observed lengthening of the anteromedial bundle at high flexion angles supports the notions of differential recruitment and reciprocal function. 21 Recently, however, the traditional view of the antero- medial and posterolateral bundles acting reciprocally to limit anterior translation through a full range of motion has been challenged. 51 In vivo data from Li and colleagues demonstrates shortening of both the anteromedial and posterolateral bundles as the knee moves from full extension to 90 degrees of flexion. 51 The most significant decrease in length occurs in the posterolateral bundle, which was observed to shorten up to 14%. The most marked shortening occurs at flexion angles beyond 60 degrees. These findings support the role of the posterolateral bundle in limiting anterior translation at low flexion angles, and challenge the traditional notion that the anteromedial bundle reciprocates at higher flexion angles. A significant strength of this study is the fact that data were obtained during activity that permitted the dynamic tension provided by the hamstrings and extensor mechanism to be taken into account with respect to cruciate ligament behavior.
In vivo studies have shown muscular activation to significantly increase ACL strain. In particular, quadriceps activity produces a marked increase in ACL strain, most pronounced in full extension. 9 Gastrocnemius activity has also been shown to increase ACL strain at low flexion angles, yielding a cumulative strain during cocontraction with the quadriceps that is significantly greater than that produced by the quadriceps alone. 27 Hamstring contraction decreases ACL strain at all flexion angles, but may not provide significant protection at very low flexion angles given the decrease in mechanical advantage experienced near full extension. 11 Beynnon and colleagues have generated the most comprehensive characterization of in vivo strain experienced by the ACL. Using a Hall effect transducer implanted in the anteromedial bundle of the ACL, Beynnon and colleagues directly measured strains during a wide variety of maneuvers. 10, 11, [23] [24] [25] [26] The highest recorded strains were during isometric quadriceps contraction (30 N/m extension torque) at 15 degree flexion, and approached 5%. Anterior shear loads applied at 30°of flexion (Lachman test) produced significantly greater strain than similar loads applied at 90 degrees of flexion (anterior drawer test), which correlates with the acknowledged superior clinical sensitivity of the Lachman test over the anterior drawer test in the detection of ACL injury. Limiting the clinical significance of these findings, however, is that strain measurements were isolated to the anteromedial bundle of the ACL. The findings of Li and colleagues suggest that studies limited to measurement of the anteromedial bundle are vulnerable to significant underestimation of the more relevant strains experienced by the posterolateral bundle.
In vitro studies have shown that the ACL has a load-to-failure as high as 2,160 N, a stiffness of 242 N/mm and is able to tolerate up to 20% strain before failure. 16, 28, 63, 77 The structural properties of the ACL, along with those of several tissues used as grafts for ACL reconstruction are listed in Table 1 . The behavior of the load-displacement curve for the ACL has been shown to vary in response to several variables, including rate of load application, immobilization, and age. In particular, more energy is required to reach load-to-failure at high load rates versus slow load rates, brief periods of immobilization can result in significant decreases in load-to-failure and older individuals demonstrate a load-to-failure up to 3 times lower than that for young individuals. 60 -62 
ANATOMY AND BIOMECHANICS OF THE PATELLAR TENDON AND BONE-PATELLAR TENDON-GRAFT Anatomy
The anatomy of the patellar tendon (PT) has been well-described. 8 The PT has a broad, flat origin along the distal, anterior aspect of the patella. The apex of the distal pole of the patella corresponds to a point medial to the midpoint of the PT, limiting its usefulness as a landmark when harvesting the central one-third of the PT for ACL reconstruction. According to one cadaveric study, slightly over 60% of the PT width lies lateral to the apex of the distal pole. Fibers of the PT converge distally in the frontal plane, resulting in a tendon thicker distally than proximally. This fascicular convergence can result in a graft that narrows from proximal to distal if dissection along strict fascicular lines is used during graft harvest.
The PT receives its vascularity from the infrapatellar fat pad and surrounding patellar retinaculum via anastamoses from both the inferomedial and inferolateral geniculate arteries. 55 The anterior surface of the PT is supplied via retinacular tissues while the infrapatellar fat pad supplies the posterior surface of the PT (Fig. 6) . The blood supply enters predominantly at the proximal and midportions of the tendon, and proximal and distal attachment sites of the tendon are relatively avascular. 72 Water constitutes approximately 70% of the wet weight of the PT, and collagen approximately 70% of the dry weight. 55 Over 90% of the collagen present in the PT is type I, with the remaining 10% comprising a distribution of types III, intravenously, V and VI. These collagen bundles are organized into large-diameter fibrils (Ͼ100 nm) with a characteristic crimp pattern that differs from that of the ACL. Of note is that proximal and distal attachments of the patellar tendon possess the same direct insertional architecture as those of the ACL, and this architecture is preserved when BPTB is used as a graft for ligament reconstruction. 18, 19, 52, 79 Soft tissue grafts do not incorporate with this type of graduated interface. 31 This may represent a biomechanical advantage of the BPTB graft over soft tissue grafts in terms of the ability to dissipate longitudinal and shear stresses in a manner more analogous to that of the native ACL. 39 
Biomechanics
The PT routinely experiences high tensile forces. Simple activities of daily living such as ascending stairs are estimated to generate tensile forces in the PT over 3.2 times body weight, with even higher forces generated during athletic activities. 59 The ultimate load-to-failure for a centrally harvested 10 mm PT graft has been measured as high as 2,977 N. 20 The fate of the defect left by harvesting the central portion of the PT has been an area of active investigation, particularly in the Scandinavian literature. 42, 45, 76 Multiple long-term follow up studies using magnetic resonance imaging and ultrasound modalities indicate that even 6 to 10 years after harvest, though completely healed, the central area of the PT remains abnormal (Fig.  7) . 42, 76 Histology of replacement tissue also differs significantly from normal PT in terms of cellularity and vascularity as far out as 2 years after harvest. 45 These morphologic abnormalities appear to be independent of whether the tendon defect was closed. What has been significantly correlated with closure of the harvest defect, however, is shortening of the PT, patella infera, and patellofemoral arthrosis. 41 In addition to altered radiographic appearance and histology, canine models suggest that as far out as 12 months after harvesting the central portion of the PT, structural and material properties of the replacement tissue are significantly inferior to those of normal tendon tissue. 14, 50 These findings, along with those from the Scandinavian literature make it difficult to recommend reharvest of the central portion of the PT as a viable option in ACL reconstruction.
BIOLOGY OF GRAFTORPORATION
Healing of any ACL reconstruction must be considered along both the intraarticular and extraarticular portions of the graft. The intraarticular portion of the graft undergoes a process of donor cell necrosis, infiltration by local cell population and a series of morphologic, histologic, and vascular changes collectively termed "ligamentization." 1 Through this process the donor tissue gradually acquires structural and material properties similar to those of the native ACL, a process that may take up to 3 years in humans. 1, 69 
Ligamentization
The timeline for ligamentization to occur has been investigated extensively in a variety of animal models, but not been well-delineated in humans. 12, 15, 19, 40, 47, 57, 79 Studies in humans are limited primarily to uncontrolled, observational designs. 22, 37, 38, 43, 69, 70 Nevertheless, in the absence of more rigorous data, the findings from these observational studies can provide a framework within which to consider the evolution of the graft tissue after transplantation. Rougraff and colleagues observed a 4-stage ligamentization process for human BPTB autografts. 69 This 4-stage process comprises an early "repopulation" stage that lasts until 2 months postreconstruction, a "rapid remodeling" stage from 2 until 10 months, a "maturation" stage from approximately 1 to 3 years and finally, a "quiescent" stage.
Stage I: Repopulation (0 -2 months)
According to Rougraff's conceptual framework, ligamentization begins with repopulation days to weeks after reconstruction as intrinsic graft fibroblasts die and are replaced via migration of local fibroblasts into the transplanted tissue. 48, 69 In small animal models this process has been observed to be complete as early as 4 weeks postreconstruction. 48 Repopulation of the transplanted graft tissue with local fibroblasts results in hypercellularity of the graft during this stage, with a nuclear morphology that is predominantly spindle or ovoid in shape, representative of a relatively high cellular meta- bolic state. The collagen ultrastructure of the native graft remains preserved early in this stage, but a process of replacement with immature collagen secreted by immigrant fibroblasts is soon initiated. Neovascularization of the graft also commences in this stage, with surface and intrasubstance proliferation of vessels likely arising from pseudoligamentum mucosum (synovium) and infrapatellar fat pad (Fig. 8) . 5, 22 Stage II: Rapid Remodeling (2-10 months) A period of increasing cellularity, increasing immature collagen content and surface hypervascularity of periligamentous tissue follows, during which the graft undergoes significant remodeling. 22, 69, 75 Coincident with these morphologic and histologic change that occur within the intraarticular portion of the graft (particularly during the remodeling phase) are significant changes in the structural and material properties of the graft.
Regardless of graft selection, a precipitous drop in biomechanical properties occurs soon after transplantation, followed by a slow return toward (but likely never reaching) baseline values. 15, 19 During this remodeling phase the graft is likely most susceptible to elongation in response to exogenous strain. The precise behavior of the load-elongation curve for grafts during the remodeling phase is unknown, but based on clinically observed graft elongation as measured by KT-1000 arthrometer, the slope of the curve can be assumed to diminish significantly. Periodic monitoring of graft stiffness with KT-1000 arthrometer measurements may be valuable during this stage of graft evolution.
Material properties, however, are not the only consideration when it comes to the risk of graft elongation. The distance separating the fixation points of the graft, ie, the functional length of the graft, also weighs into this risk. Assuming identical biomechanical environments after reconstruction, as well as identical graft material properties, a graft with a greater functional length at time zero (t 0) will experience greater elongation. For example, graft 1 with a t 0 length of L and strain of ⑀ will experience one-half the elongation than graft 2 with a t 0 length of 2L and the same strain ⑀:
In practical terms, these concerns may become important when considering a soft tissue graft with fixation points distant to the joint line versus a BPTB construct with aperture femoral-sided fixation and tibial-sided fixation that approaches aperture in nature. The soft tissue graft in this hypothetical situation presents a greater   FIG. 8. (A) A 5-mm-thick sagittal section of a canine knee cleared by the Spalteholz technique, 2 weeks after replacement with a patellar tendon graft. The graft (PTG) shows no evidence of perfused vessels. Note the absence of vessels crossing the tibial attachment of the graft (arrow). (The infrapatellar fat pad and posterior cruciate ligament were removed after clearing to permit better visualization.) F ϭ femur, T ϭ tibia, and PT ϭ patellar tendon. (B) A 5-mm-thick sagittal section of a dog's knee 6 weeks after replacement of the anterior cruciate ligament with a patellar tendon graft (PTG). Note the vascular response of the infrapatellar fat pad (FP) and posterior soft tissues (PST). Vessels from the fat pad can be seen extending over the surface of the patellar tendon graft (arrows) and are part of the vascular synovial envelope. Note that the tibial attachments of the graft (white arrows) do not contribute to any vessels to the graft. F ϭ femur, T ϭ tibia, PT ϭ patellar tendon, and P ϭ patella (Reprinted, with permission, from: Arnoczky SP, Tarvin GB, Marshall JL. Anterior cruciate ligament replacement using patellar tendon: an evaluation of graft revascularization in the dog. functional length, possibly making it vulnerable to greater elongation than the BPTB graft.
Stage III: Maturation (10 -36 months)
At approximately 12 months postreconstruction, the graft enters a maturation phase, during which the cellularity and metabolic activity of the graft decreases, the collagen structure continues to mature and the vascularity of the graft (at least as measured at the graft surface) drops to values near those typical of normal, control ACLs (Fig. 9) . 22, 69, 75 Furthermore, improvements in the biomechanical properties of the graft may also occur during this period.
There is evidence that graft maturation occurs at a slower rate in allograft tissue than in autograft tissue, with potential implications for activity progression during postoperative rehabilitation. 37, 40 Additional considerations with potentially deleterious implications for the biomechanical performance of currently available allografts include the age of the donor and use of irradiation for graft sterilization. Even small amounts of irradiation can result in significant weakening of allograft tissue. 32, 67 Stage IV: Quiescent Eventually the graft is thought to enter a quiescent phase during which cellularity and collagen structure approach that of baseline ACL levels. The time necessary to reach this stage likely varies somewhat from patient to patient and from graft type to graft type, but may take up to 3 years. 69 
Graft Fixation and Tunnel Incorporation
At time zero after anterior cruciate ligament reconstruction, the proximal and distal fixation points represent the weakest element of the construct. Interference screws are the most commonly used means of obtaining initial rigid fixation of BPTB grafts. Biomechanical studies in human cadaveric specimens have reported initial pull-out strengths of BPTB grafts fixed with metallic interference screws to range from 362 N to 640 N, though the donor age for the specimens tested in these studies was much higher than that of the average patient undergoing ACLR, and these values may therefore underestimate the true fixation strength provided by interference screws. 13, 17, 64 Considering the highest of these values, the pull-out strength of the graft at time zero would be only 30% of the load-to-failure of the native ACL, and 27% of the load-to-failure of the tendinous portion of a 10 mm BPTB graft. In addition to bone quality, the geometry of interference screw-bone block contact is another factor affecting initial holding strength. Interference screws should be placed parallel to bone blocks to provide optimal fixation strength. As little as 15 degree divergence can reduce initial fixation strength by as much as 50%. 65 Additionally, distal interference screw head engagement of the tibial cortex may provide superior fixation strength to cancellous purchase alone. 36 With respect to ACL reconstruction using BPTB autograft, interference screw fixation does not vary significantly with screw length, diameter or material (metallic versus bioabsorbable). 13, 44, 56, 64 The incorporation of graft bone-plugs into host tunnels occurs through appositional bone formation (Fig.  10) . 39, 79 This process has been observed to be complete (with no discernable interface identifiable by light microscopy) as early as 12 weeks postreconstruction in a canine model. 79 Intrasubstance, traumatic rupture of autogenous hamstring grafts secured with interference screw fixation has been reported as early as 6 weeks postreconstruction, suggesting that significant soft tissue incorporation occurs at a relatively rapid rate. 66 Though incorporation of bone plugs into tunnels is likely more rapid than incorporation of soft-tissue grafts, perhaps occurring at between 4 and 6 weeks, the precise timecourse of tunnel incorporation in humans has not been described.
Incorporation of patellar tendon into surrounding bone tunnel is likely of secondary structural concern. Observational studies comprising specimens retrieved from patients undergoing revision ACLR demonstrate an "in- direct" type of tendon-to-bone attachment consisting of Sharpey-like collagen fibers perpendicular to the orientation of the graft fibers anchoring to adjacent bone. 39, 79 
Use of Biologics
During the process of ligamentization, manipulation of the load-elongation curve would theoretically facilitate safe, accelerated rehabilitation after reconstruction. Such manipulation may be possible using a variety of growth factors, as demonstrated in recent rabbit and canine models. 6, 78 Yasuda and colleagues investigated the effects of transforming growth factor-␤ and epidermal growth factor on the histologic and biomechanical properties of bone-patellar tendon-bone autografts in a canine model. 78 Animals were killed at 12 weeks postreconstruction and grafts taken from the treatment group demonstrated significantly greater stiffness and load-to-failure than those taken from the sham group. Additionally, the histology of the growth factor-treated grafts-though different from that of the normal ACL-demonstrated less cellularity, more regular crimp pattern and more linear fibril orientation than grafts in the sham group, indicative of an accelerated maturation process.
The use of growth factors to accelerate graft incorporation into bone tunnels is also under investigation. 3, 54, 68 Rodeo and colleagues reported trends but no significant difference in the pull-out strength between treatment (bone morphogenic protein-2) and control groups with respect to soft-tissue graft healing to a bone tunnel at 4 and 8 weeks postimplantation. 68 Anderson and colleagues used a heterogeneous mix of growth factors in a rabbit model and found a significant increase in the load-to-failure of treated semitendinosus ACL reconstructions versus controls at 2, 4, and 8 weeks after reconstruction. 3 These authors also observed occasional formation of a direct (4-layer) tendon interface rather than indirect (Sharpey fibers) interface in the treatment group. Martinek and colleagues transfected autogenous semitendinosus grafts with the gene for bone morphogenic protein-2 and used the construct for ACL reconstruction in a rabbit model. 54 Both graft stiffness and load-to-failure were significantly increased in the treatment group versus the control group at 8 weeks postreconstruction. Though evidence is increasing to support the use of biologics to accelerate both ligamentization and graft incorporation, further study is needed before introducing their use in clinical practice.
CONCLUSION
There are many graft choices available for reconstruction of the anterior cruciate ligament. The BPTB autograft harvested from the central portion of the patellar tendon is well-suited for ACL reconstruction from anatomic, biologic, and biomechanical perspectives. The timeline and biomechanical implications of graft ligamentization represent the rate-limiting step in advancing activity postreconstruction, but lack of precise knowledge of this timeline in humans makes strict correlation between rehabilitation protocols and graft healing problematic. Nevertheless, the use of biologics holds promise for acceleration of graft healing and more rapid return to unrestricted activity. 
